Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting of case studies and series on drug-induced QT interval prolongation and its complications following acute overdose. |
| Full bibliographic reference | Berling I, Hatten BW, Hoffman RS, Othong R, Roberts DM, Mustafa RA, Yates C, Cormier M, Gosselin S. Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose. Clin Toxicol (Phila). 2019:1-9. |
| Language | English |
| PubMed ID | 31018700 |
| Study design | Observational studies |
| Clinical area | Cardiovascular medicine, Emergency medicine, Pharmaceutical medicine, Toxicology |
| Applies to the whole report or to individual sections of the report? | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Study characteristics (participants etc.) |
| Record last updated on | November 28, 2019 |